News & Events

Publications

Health Affairs
Health Technology Assessment, Again: A Transparent, Evidence-Based Approach For CMS Drug Price Negotiations
Journal of Comparative Effectiveness Research
Value assessment for health services and procedures: a call to action in a new political climate
Health Affairs Scholar
What drug characteristics explain the wide range of manufacturer rebates?
Value in Health
Achieving Patient-Centered Value/Health Technology Assessment: Recommendations From a Multistakeholder eDelphi Panel
Health Affairs
Drug coverage policies and clinical guidelines alignment: Most coverage decisions include additional restrictions
Frontiers in Pharmacology
Value attribution for oncology combination regimens: going beyond frameworks to balance innovation, access, and affordability
Value in Health
Health utilities in Alzheimer's disease: A survey of patients and caregivers in the United States
Value in Health
US Drug Pricing Patterns Before Loss of Exclusivity
Health Affairs Scholar
An analysis of US net cancer drug launch prices and clinical efficacy and certainty of evidence from 2008 to 2022